Sphera Funds Management »

Vaxcyte shares owned by Sphera Funds Management

Quarter-by-quarter ownership of Vaxcyte (PCVX) shares owned by Sphera Funds Management from 13F filings

Historical chart of Sphera Funds Management investment in Vaxcyte

Tip: Access up to 7 years of quarterly data

All positions including Vaxcyte held by Sphera Funds Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaxcyte by Sphera Funds Management

Quarter filed Position value Share count Share price at filing
2023-03-31 $3.4M 90k 37.48

More positions owned by Sphera Funds Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Sanofi Sponsored Adr (SNY)
Cytokinetics Com New (CYTK)
NOVA MEASURING Instruments L (NVMI)
Celldex Therapeutics Com New (CLDX)
Syndax Pharmaceuticals (SNDX)
Tower Semiconductor Shs New (TSEM)
Nice Sponsored Adr (NICE)
Merck & Co (MRK)
Johnson & Johnson (JNJ)
Meta Platforms Cl A (META)
Astrazeneca Sponsored Adr (AZN)
Biogen Idec (BIIB)
Bridgebio Pharma (BBIO)

View all positions for Sphera Funds Management

Top funds holding Vaxcyte

Vanguard Group
RA Capital Management
Henderson Group
Wellington Management Company
T. Rowe Price Associates
Alliancebernstein
Fred Alger Management
Jennison Associates
Westfield Capital Management Company
Braidwell
Frazier Life Sciences Management
OrbiMed Advisors
Commodore Capital
Perceptive Advisors
Franklin Resources

View all funds holding Vaxcyte